Provided by Tiger Trade Technology Pte. Ltd.

AKESO

93.600
-1.450-1.53%
Volume:7.15M
Turnover:672.65M
Market Cap:86.21B
PE:-65.01
High:96.000
Open:95.050
Low:93.400
Close:95.050
52wk High:156.000
52wk Low:80.200
Shares:921.00M
HK Float Shares:921.00M
Volume Ratio:0.46
T/O Rate:0.78%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.440
ROE:-13.59%
ROA:-4.57%
PB:8.70
PE(LYR):-65.01
PS:21.39

Loading ...

Movement Alert|Akeso Bio Falls 3.05% in Regular Trading, Trading at HK$90.5

Market Focus
·
Jul 21

Akeso Says Press Release Available on Phase II Dosing of Ak146d1 with Ivonescimab in Advanced NSCLC

Reuters
·
Jul 20

Akeso Doses First Patient in Phase Ii Study of Novel Trop2/nectin-4 Bispecific ADC (ak146d1) in Combination with Ivonescimab for Advanced Nsclc

THOMSON REUTERS
·
Jul 20

HK Movers | Biomedical Stocks Rally; REMEGEN, WUXI XDC and KEYMED BIO-B Surge Over 8%

Tiger Newspress
·
Jul 20

Movement Alert|Akeso Rises 3.17% in Regular Trading, Biotech Sector Rallies Broadly with Multiple Buy Ratings Reaffirmed

Market Focus
·
Jul 20

Movement Alert|Akeso Bio Falls 3.63% in Regular Trading, Trading at 93.0 HKD

Market Focus
·
Jul 17

Innovative Drug Stocks Surge Following Inclusion in National Essential Medicines List, Accelerating Grassroots Access

Stock News
·
Jul 15

Movement Alert|Akeso Rises 3.86% in Regular Trading, Partners with Top US Cancer Center to Advance Cadonilimab International Clinical Trials

Market Focus
·
Jul 15

Akeso Launches US Phase II Trial of Cadonilimab Combination in Perioperative Gastric Cancer

Reuters
·
Jul 14

Phase Ii Trial of Cadonilimab(pd-1/ctla-4) Combination Regimen Launches in the United States for Perioperative Treatment of Gastric Cancer

THOMSON REUTERS
·
Jul 14

Movement Alert|Akeso Falls 3.08% in Regular Trading, Trading at 94.25 HKD

Market Focus
·
Jul 13

Movement Alert|Akeso Bio Rises 4.38% in Regular Trading, Innovative Drug Payment Reform Continues to Catalyze Amid Sector-Wide Strength

Market Focus
·
Jul 10

Movement Alert|Akeso Rises 3.32% in Regular Trading, Innovative Drug Payment Reform Continues to Catalyze Alongside Sector Strength

Market Focus
·
Jul 09

Movement Alert|Akeso Rises 3.12% in Regular Trading, Innovative Drug Payment Reform Catalysts Continue After Prior Session Pullback

Market Focus
·
Jul 08

Movement Alert|Akeso Bio Falls 3.24% in Regular Trading, Biotech Sector Broadly Retreats After Recent Rally

Market Focus
·
Jul 07

Movement Alert|Akeso Rises 3.32% in Regular Trading, Innovative Drug Payment Reform Continues to Catalyze Amid Sector-Wide Strength

Market Focus
·
Jul 06

Movement Alert|Akeso Inc Rises 4.8% in Regular Trading, Innovative Drug Payment Reform Catalyzes Biotech Sector Rally

Market Focus
·
Jul 03

Movement Alert|Akeso Bio Rises 6.3% in Regular Trading, Biotech Sector Rally and AI Drug Platform Progress Fuel Rebound

Market Focus
·
Jul 02

Movement Alert|Akeso Falls 3.06% in Regular Trading, Technical Profit-Taking After Previous Session 13% Rally Amid Sector-Wide Weakness

Market Focus
·
Jun 30

Akeso Shareholders Back 2025 Financial Statements at Annual Meeting

Reuters
·
Jun 29